What are the adverse reactions of Fostamatinib?

Fostamatinib (Fostamatinib) is a drug specifically designed to treat chronic immune thrombocytopenia (ITP) that has had an inadequate response to previous therapy. It is mainly suitable for adult patients. Despite showing promising efficacy in clinical trials, fotantinib is associated with a variety of potential side effects.

Common side effects

1. Diarrhea: Diarrhea is one of the most common side effects of fotantinib, which may affect the patient's daily life and diet. In severe cases, it can lead to dehydration and malnutrition.

2. Hypertension: Fotantinib may cause blood pressure to increase, so patients need to monitor blood pressure regularly to reduce the risk of cardiovascular disease.

3. Nausea and vomiting: Many patients report nausea, sometimes accompanied by vomiting, which affects their appetite and ability to eat.

4. Respiratory tract infections: Because fotantinib may have an impact on the immune system, patients are more susceptible to infections, especially respiratory tract infections, during treatment.

5. Dizziness and fatigue: Many patients will feel dizziness and persistent fatigue, which may interfere with their daily activities and work efficiency.

6. Abnormal liver function: Increased liver enzyme levels are an important side effect that requires attention, so liver function indicators should be monitored regularly during treatment.

Other side effects

Although rash, abdominal pain, and chest pain are relatively rare, patients should consult their doctor promptly if these symptoms occur.

Decreased white blood cell count is also one of the problems that may occur with fotantinib, increasing the patient's risk of infection.

serious side effects

In individual cases, patients may experience serious adverse reactions, such as dyspnea and significant hypertension, which require special attention. In addition, symptoms such as neutropenia, joint pain, kidney stones, limb pain, toothache, syncope, and hypoxia should also be closely monitored.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21149cc3-049b-43e2-b141-c9499160556c